US tariffs
Increase in costs affecting gross margins.
- Materiality
- high
Senzime
Senzime is a global medical technology company specializing in algorithm-based patient monitoring systems aimed at reducing anesthesia-related complications. The company's flagship product, the TetraGraph system, is used in thousands of operating rooms worldwide to provide precision-based monitoring during and after surgery. Senzime collaborates with leading academic institutions and operates in over 30 markets, with subsidiaries in the US and Germany. The company is listed on the Nasdaq Main Market Stockholm and is recognized for its rapid growth and innovation in medical technology.
3.76
2.67
| % | |
|---|---|
| Neuromuscular Monitoring Systems | 50% Includes TetraGraph systems for precision-based patient monitoring. |
| Software Solutions | 20% Includes EMGINE™ Sirius software for enhanced monitoring capabilities. |
| Disposable Sensors | 20% Single-use sensors for patient monitoring during surgeries. |
| Licensing and Partnerships | 10% Revenue from licensing and distribution agreements. |
Senzime's customers primarily include hospitals and healthcare institutions that require advanced patient monitoring...
- Hospitalsprimary
Purchase TetraGraph systems for precision-based monitoring to improve surgical outcomes.
- Academic Medical Centerssecondary
Collaborate on research and use systems to meet clinical guidelines.
- International Distributorsemerging
License and distribute Senzime products in various regions.
Senzime operates globally, with commercial activities in over 30 markets. The company has subsidiaries in the US and...
- •Global operations in over 30 markets
- •Key subsidiaries in the US and Germany
- •Licensing and distribution partnerships in various regions
- •No operations in geopolitically sensitive areas like Russia
Senzime's strategic priorities include accelerating growth and achieving profitability by 2026...
01
Accelerate growthmedium-term
To surpass revenue milestones and strengthen market position.
02
Achieve profitabilitylong-term
To ensure sustainable financial performance.
03
Product innovationshort-term
To maintain competitive edge and meet clinical needs.
Senzime faces several risks, including financial and operational challenges. The introduction of new US tariffs poses a...
Currency fluctuations
Stronger Swedish krona negatively impacts sales.
- Materiality
- medium
Regulatory changes
Need to comply with evolving clinical guidelines.
- Materiality
- medium
Currency effects recognition
Alternative performance measures
Getinge
GETI-B.ST · Health Care
Getinge AB is a global provider of products and solutions for healthcare and life sciences, focusing on intensive care, cardiovascular procedures, operating…
Hyperfine, Inc.
HYPR · Electromedical & Electrotherapeutic Apparatus
Senseonics Holdings, Inc.
SENS · Industrial Instruments For Measurement, Display, and Control
Sensus Healthcare, Inc.
SRTS · Surgical & Medical Instruments & Apparatus
HALOZYME THERAPEUTICS, INC.
HALO · Biological Products, (No Diagnostic Substances)
Halozyme Therapeutics is a biopharmaceutical company built around drug-delivery technologies rather than a broad portfolio of branded medicines.
ENvue Medical, Inc.
FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies
: 11/08/2026